The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss ...

Switzerland-based pesticides maker Syngenta said on Wednesday that it has acquired a repository of natural compounds and ...

(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.

Experts discuss the crucial role of government in enhancing India's participation in clinical trials at BioAsia 2025 panel.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Emasan AG is offering around 26.5M shares in Swiss Novartis (NVS) through Goldman Sachs, potentially raising $3B, Pablo Mayo Cerqueiro of ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

In earlier times, people prepared food from resources found in their immediate area, with their nutritional values passed on from the wisdom of ancestors who studied their forests and plants that ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Forty-one-year old Homer Perey had to make a very difficult and life-changing decision last year. Around August 2024, Perey decided to have his lower left limb amputated because he could no longer ...

Xealth, the leader in enabling digital health at scale, today announced that CEO and Co-founder Mike McSherry will join UPMC ...

The prevalence of type 2 diabetes is rising globally, with a disproportionate impact on individuals in low-income and middle-income countries, where access to care and new therapies is often limited.